NCT03055650View on ClinicalTrials.gov

iLux Treatment for Meibomian Gland Dysfunction (MGD)

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 7, 2015

Primary Completion Date

February 18, 2016

Study Completion Date

February 18, 2016

Conditions
Evaporative Dry Eye
Interventions
DEVICE

iLux 2020 System

Medical device that applies localized heat and pressure therapy to the eyelid in order to express melted meibum from obstructed glands

Trial Locations (3)

92122

TearFilm Investigative Site, San Diego

92128

TearFilm Investigative Site, San Diego

92924

TearFilm Investigative Site, Encinitas

All Listed Sponsors
lead

Tear Film Innovations, Inc.

INDUSTRY

NCT03055650 - iLux Treatment for Meibomian Gland Dysfunction (MGD) | Biotech Hunter | Biotech Hunter